Biopsychosocial approach to persistent post-mastectomy pain: What can we conclude?

Pain

Volumn 154, Issue 5, 2013, Pages 623-624

  Anderson, Karen O ^a   Reyes Gibby, Cielito C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMLA; MEXILETINE;

ANXIETY; BIOPSYCHOSOCIAL APPROACH; BREAST CANCER; CANCER SURGERY; CANCER SURVIVOR; CATASTROPHIZING; CHRONIC PAIN; DEPRESSION; DISTRESS SYNDROME; EMOTIONAL STRESS; FEMALE; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MASTALGIA; NERVE INJURY; NEURALGIA; NEUROMA; NOCICEPTION; NOTE; PAIN ASSESSMENT; PHANTOM PAIN; POSTMASTECTOMY PAIN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; SLEEP DISORDER; SOMATIZATION; TEMPORAL SUMMATION;

EID: 84878019268     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2013.02.020     Document Type: Editorial

References (16)

1. American Cancer Society. Breast cancer facts and figures 2011-2012. Atlanta : American Cancer Society Inc.; 2012.
2. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain 2011;12:725-46.
3. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002;95:985-91. table.
4. Fassoulaki A, Sarantopoulos C, Melemeni A, Hogan Q. EMLA reduces acute and chronic pain after breast surgery for cancer. Reg Anesth Pain Med 2000;25:350-5.
5. Fecho K, Miller NR, Merritt SA, Klauber-Demore N, Hultman CS, Blau WS. Acute and persistent postoperative pain after breast surgery. Pain Med 2009;10:708-15.
6. Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. PAIN 2003;104:1-13.
7. Kudel I, Edwards RR, Kozachik S, Block BM, Agarwal S, Heinberg LJ, Haythornthwaite J, Raja SN. Predictors and consequences of multiple persistent postmastectomy pains. J Pain Symptom Manage 2007;34:619-27.
8. Miaskowski C, Cooper B, Paul SM, West C, Langford D, Levine JD, Abrams G, Hamolsky D, Dunn L, Dodd M, Neuhaus J, Baggott C, Dhruva A, Schmidt B, Cataldo J, Merriman J, Aouizerat BE. Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain 2012;13:1172-87.
9. Mogil JS. Pain genetics: past, present and future. Trends Genet 2012;28: 258-66.
10. Nissenbaum J, Devor M, Seltzer Z, Gebauer M, Michaelis M, Tal M, Dorfman R, Abitbul-Yarkoni M, Lu Y, Elahipanah T, DelCanho S, Minert A, Fried K, Persson AK, Shpigler H, Shabo E, Yakir B, Pisante A, Darvasi A. Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res 2010;20:1180-90.
11. Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, Dworkin RH. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 2006;7:626-34.
12. Reyes-Gibby CC, Morrow PK, Buzdar A, Shete S. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain 2009;10:1146-50.
13. Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, Shete S. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008;9:777-85.
14. Schreiber KL, Martelz MO , Shnol H, Shaffer JR, Greco C, Viray N, Taylor LN , McLaughlin M, Brufksy A, Ahrendt G, Bovbjerg D, Edwards RR, Belfer I. Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical and psychosocial characteristics between patients with and without pain. PAIN 2013;154:660-8.
15. Sheridan D, Foo I, O'Shea H, Gillanders D, Williams L, Fallon M, Colvin L. Longterm follow-up of pain and emotional characteristics of women after surgery for breast cancer. J Pain Symptom Manage 2012;44:608-14.
16. Tasmuth T, Kataja M, Blomqvist C, Vonz SK , Kalso E. Treatment-related factors predisposing to chronic pain in patients with breast cancer: a multivariate approach. Acta Oncol 1997;36:625-30.